Johnson & Johnson
NYSE:JNJ

Watchlist Manager
Johnson & Johnson Logo
Johnson & Johnson
NYSE:JNJ
Watchlist
Price: 153.24 USD 0.39% Market Closed
Market Cap: 368.9B USD
Have any thoughts about
Johnson & Johnson?
Write Note

Wall Street
Price Targets

JNJ Price Targets Summary
Johnson & Johnson

Wall Street analysts forecast JNJ stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JNJ is 178.37 USD with a low forecast of 151.5 USD and a high forecast of 225.75 USD.

Lowest
Price Target
151.5 USD
1% Downside
Average
Price Target
178.37 USD
16% Upside
Highest
Price Target
225.75 USD
47% Upside

JNJ Last Price Targets
Johnson & Johnson

The latest public price target was made on Oct 16, 2024 by Terence Flynn from Morgan Stanley , who expects JNJ stock to rise by 14% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Terence Flynn
Morgan Stanley
175 USD
Upside 14%
4 weeks ago
Oct 16, 2024
Johnson & Johnson price target raised to $175 from $169 at Morgan Stanley
TheFly
Joanne Wuensch
Citigroup
185 USD
Upside 21%
4 weeks ago
Oct 16, 2024
Johnson & Johnson price target raised to $185 from $180 at Citi
TheFly
Shagun Singh
RBC Capital
181 USD
Upside 18%
4 weeks ago
Oct 16, 2024
Johnson & Johnson (JNJ) PT Raised to $181 at RBC Capital
StreetInsider
Chris Shibutani
Goldman Sachs
159 USD
Upside 4%
4 weeks ago
Oct 16, 2024
Johnson & Johnson price target lowered to $159 from $162 at Goldman Sachs
TheFly
Joanna Wuensch
Citigroup
180 USD
Upside 17%
4 weeks ago
Oct 15, 2024
Citi Reiterates Buy Rating on Johnson & Johnson (JNJ)
StreetInsider
Rick Wise
Stifel Nicolaus
170 USD
Upside 11%
4 weeks ago
Oct 15, 2024
Johnson & Johnson (JNJ) PT Raised to $170 at Stifel
StreetInsider
Larry Biegelsen
Wells Fargo
166 USD
Upside 8%
4 weeks ago
Oct 15, 2024
Johnson & Johnson price target raised to $166 from $163 at Wells Fargo
TheFly
Louise Chen
Cantor Fitzgerald
215 USD
Upside 40%
1 month ago
Oct 14, 2024
Johnson & Johnson Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Benzinga
Narumi Nakagiri
Johnson Rice
150 USD
Downside 2%
3 months ago
Jul 23, 2024
Johnson & Johnson downgraded to Neutral from Outperform at Daiwa
TheFly
Rick Wise
Stifel Nicolaus
160 USD
Upside 4%
3 months ago
Jul 17, 2024
Johnson & Johnson price target raised to $160 from $155 at Stifel
TheFly
Chris Shibutani
Johnson Rice
160 USD
Upside 4%
5 months ago
May 30, 2024
Johnson & Johnson reinstated with a Neutral at Goldman Sachs
TheFly
Chris Shibutani
Goldman Sachs
160 USD
Upside 4%
5 months ago
May 30, 2024
Goldman Sachs Reinstates Johnson & Johnson (JNJ) at Neutral
StreetInsider
Danielle Antalffy
UBS
180 USD
Upside 17%
5 months ago
May 22, 2024
UBS Reiterates Buy Rating on Johnson & Johnson (JNJ)
StreetInsider
Morten Herholdt
Johnson Rice
170 USD
Upside 11%
6 months ago
Apr 18, 2024
HSBC Upgrades Johnson & Johnson (JNJ) to Buy, 'Steady outlook, low expectations'
StreetInsider
Shagun Singh
RBC Capital
175 USD
Upside 14%
6 months ago
Apr 17, 2024
Johnson & Johnson (JNJ) PT Lowered to $175 at RBC Capital
StreetInsider
Louise Chen
Johnson Rice
215 USD
Upside 40%
6 months ago
Apr 17, 2024
Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results
Benzinga
Rick Wise
Stifel Nicolaus
155 USD
Upside 1%
6 months ago
Apr 16, 2024
Johnson & Johnson (JNJ) PT Lowered to $155 at Stifel
StreetInsider
Jayson Bedford
Raymond James
175 USD
Upside 14%
7 months ago
Mar 27, 2024
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga
Terence Flynn
Morgan Stanley
169 USD
Upside 10%
7 months ago
Mar 27, 2024
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
Benzinga
Larry Biegelsen
Wells Fargo
163 USD
Upside 6%
10 months ago
Dec 28, 2023
Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
Benzinga
Jayson Bedford
Raymond James
110 USD
Downside 28%
10 months ago
Dec 28, 2023
Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts
Benzinga
Shagun Singh
Johnson Rice
178 USD
Upside 16%
1 year ago
Oct 5, 2023
Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst
Benzinga
Trung Huynh
Johnson Rice
175 USD
Upside 14%
1 year ago
Jul 21, 2023
Johnson & Johnson Medtech Business Has Promising Momentum, Analysts Say After Good Q2 Performance
Benzinga
John Ransom
Raymond James
90 USD
Downside 41%
1 year ago
May 24, 2023
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
Benzinga
Show More Price Targets
Show Less Price Targets
Terence Flynn
Morgan Stanley
Price Target 175 USD
Upside/Downside 14%
View Source
Joanne Wuensch
Citigroup
Price Target 185 USD
Upside/Downside 21%
View Source
Shagun Singh
RBC Capital
Price Target 181 USD
Upside/Downside 18%
View Source
Chris Shibutani
Goldman Sachs
Price Target 159 USD
Upside/Downside 4%
View Source
Joanna Wuensch
Citigroup
Price Target 180 USD
Upside/Downside 17%
View Source
Rick Wise
Stifel Nicolaus
Price Target 170 USD
Upside/Downside 11%
View Source
Larry Biegelsen
Wells Fargo
Price Target 166 USD
Upside/Downside 8%
View Source
Louise Chen
Cantor Fitzgerald
Price Target 215 USD
Upside/Downside 40%
View Source
Narumi Nakagiri
Johnson Rice
Price Target 150 USD
Upside/Downside 2%
View Source
Rick Wise
Stifel Nicolaus
Price Target 160 USD
Upside/Downside 4%
View Source
Chris Shibutani
Johnson Rice
Price Target 160 USD
Upside/Downside 4%
View Source
Chris Shibutani
Goldman Sachs
Price Target 160 USD
Upside/Downside 4%
View Source
Danielle Antalffy
UBS
Price Target 180 USD
Upside/Downside 17%
View Source
Morten Herholdt
Johnson Rice
Price Target 170 USD
Upside/Downside 11%
View Source
Shagun Singh
RBC Capital
Price Target 175 USD
Upside/Downside 14%
View Source
Louise Chen
Johnson Rice
Price Target 215 USD
Upside/Downside 40%
View Source
Rick Wise
Stifel Nicolaus
Price Target 155 USD
Upside/Downside 1%
View Source
Jayson Bedford
Raymond James
Price Target 175 USD
Upside/Downside 14%
View Source
Terence Flynn
Morgan Stanley
Price Target 169 USD
Upside/Downside 10%
View Source
Larry Biegelsen
Wells Fargo
Price Target 163 USD
Upside/Downside 6%
View Source
Jayson Bedford
Raymond James
Price Target 110 USD
Upside/Downside 28%
View Source
Shagun Singh
Johnson Rice
Price Target 178 USD
Upside/Downside 16%
View Source
Trung Huynh
Johnson Rice
Price Target 175 USD
Upside/Downside 14%
View Source
John Ransom
Raymond James
Price Target 90 USD
Upside/Downside 41%
View Source
Show More Price Targets
Show Less Price Targets
Johnson & Johnson Competitors:
Price Targets
ORCHPHARMA
Orchid Pharma Ltd
9% Upside
4519
Chugai Pharmaceutical Co Ltd
1% Downside
600062
China Resources Double-Crane Pharmaceutical Co Ltd
20% Upside
603456
Zhejiang Jiuzhou Pharmaceutical Co Ltd
53% Upside
AVDL
Avadel Pharmaceuticals PLC
109% Upside
600285
Henan Lingrui Pharmaceutical Co Ltd
37% Upside
605507
Guobang Pharma Ltd
16% Upside
603566
Pulike Biological Engineering Inc
12% Upside

Revenue
Forecast

Revenue Estimate
Johnson & Johnson

For the last 8 years the compound annual growth rate for Johnson & Johnson's revenue is 2%. The projected CAGR for the next 3 years is 4%.

2%
Past Growth
4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Johnson & Johnson

For the last 8 years the compound annual growth rate for Johnson & Johnson's operating income is 2%. The projected CAGR for the next 3 years is 9%.

2%
Past Growth
9%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Johnson & Johnson

For the last 8 years the compound annual growth rate for Johnson & Johnson's net income is 11%. The projected CAGR for the next 3 years is -8%.

11%
Past Growth
-8%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JNJ's stock price target?
Price Target
178.37 USD

According to Wall Street analysts, the average 1-year price target for JNJ is 178.37 USD with a low forecast of 151.5 USD and a high forecast of 225.75 USD.

What is Johnson & Johnson's Revenue forecast?
Projected CAGR
4%

For the last 8 years the compound annual growth rate for Johnson & Johnson's revenue is 2%. The projected CAGR for the next 3 years is 4%.

What is Johnson & Johnson's Operating Income forecast?
Projected CAGR
9%

For the last 8 years the compound annual growth rate for Johnson & Johnson's operating income is 2%. The projected CAGR for the next 3 years is 9%.

What is Johnson & Johnson's Net Income forecast?
Projected CAGR
-8%

For the last 8 years the compound annual growth rate for Johnson & Johnson's net income is 11%. The projected CAGR for the next 3 years is -8%.

Back to Top